National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Department of Health and Human Services
Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This NOFO using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area represen
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Later
Posted
01/15/2025
Closes
2027-10-25
Eligibility
Eligibility
Public and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationSpecial district governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)City or township governmentsPrivate institutions of higher educationState governmentsCounty governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)Native American tribal governments (Federally recognized)Small businesses
Program
Funding area
Health - HL
Opportunity #
PAR-25-352
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov